DRISCOLL FREDERICK W

The estimated Net Worth of DRISCOLL FREDERICK W is at least $4 Million dollars dollars as of 11/30/2021. DRISCOLL FREDERICK W is the Director of Cellectar Biosciences Inc. DRISCOLL FREDERICK W owns over 19,417 shares of Cellectar Biosciences Inc stock worth over $13,440.45. DRISCOLL FREDERICK W is the CFO of Flexion Therapeutics Inc. DRISCOLL FREDERICK W owns over 7,777 shares of Flexion Therapeutics Inc stock worth over $70,926.24. DRISCOLL FREDERICK W is the Director of MEI Pharma Inc. DRISCOLL FREDERICK W owns over 37,500 shares of MEI Pharma Inc stock worth over $91,875.00. DRISCOLL FREDERICK W is the Director of NantKwest Inc. DRISCOLL FREDERICK W owns over 109,235 shares of NantKwest Inc stock worth over $4 Million dollars . DRISCOLL FREDERICK W is the VP, CFO & Treasurer of Novavax Inc. DRISCOLL FREDERICK W owns over 1,000 shares of Novavax Inc stock worth over $193,960.00.

Insider Roles

Name Transaction Date Position
NantKwest Inc 2020-08-11 director
MEI Pharma Inc 2020-07-02 director
Cellectar Biosciences Inc 2020-06-24 director
Cue Biopharma Inc 2020-01-02 director
Conformis Inc 2019-10-23 officer: INTERIM CFO & INTERIM TREAS
Abpro Corp 2018-05-10 director
Flexion Therapeutics Inc 2017-03-23 officer: Chief Financial Officer
Oncotelic Therapeutics Inc 2016-06-01 director
Novavax Inc 2013-03-02 officer: VP, CFO & Treasurer
EMBED
SAVE

DRISCOLL FREDERICK W trading performance

Average Relative Return

70.92%

Average relative return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .

DRISCOLL FREDERICK W trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 36.75 33.15 74.95 70.92 140.4 97.94
Relative Return to S&P 500(%) 35.88 35.2 69.03 53.95 104.21 50.07

Driscoll Frederick W trading transactions

Ticker Company Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost(000) Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
CLRB
Cellectar Biosciences Inc
$0.69
DRISCOLL FREDERICK W
Director
2021-09-03 Buy
19,417
100%
$1.04
$20.19
19,417
-33.44%
0
At Loss
42.29
MEIP
MEI Pharma Inc
$2.45
DRISCOLL FREDERICK W
Director
2021-02-23 Sell
25,000
-40%
$4.03
$100.75
37,500
-39.21%
0
At Loss
276.17
NK
NantKwest Inc
$32.49
DRISCOLL FREDERICK W
Director
2020-08-11 Sell
65,300
-37.41%
$10.23
$668.02
109,235
217.60%
0
At Loss
3,552.61
MEIP
MEI Pharma Inc
$2.45
DRISCOLL FREDERICK W
Director
2019-12-19 Buy
62,500
100%
$1.60
$100
62,500
53.13%
0
At Loss
276.17
FLXN
Flexion Therapeutics Inc
$9.12
DRISCOLL FREDERICK W
CFO
2017-03-23 Sell
3,000
-27.84%
$23
$69
7,777
-60.35%
0
At Loss
458.93
FLXN
Flexion Therapeutics Inc
$9.12
DRISCOLL FREDERICK W
CFO
2017-02-28 Sell
33,434
-81.13%
$19.97
$667.68
7,777
-54.33%
0
At Loss
458.93
FLXN
Flexion Therapeutics Inc
$9.12
DRISCOLL FREDERICK W
CFO
2016-05-17 Buy
2,500
42.13%
$9.87
$24.68
8,434
-7.60%
0
At Loss
458.93
FLXN
Flexion Therapeutics Inc
$9.12
DRISCOLL FREDERICK W
CFO
2016-05-16 Buy
2,500
72.80%
$9.19
$22.98
5,934
-0.76%
0
At Loss
458.93
NVAX
Novavax Inc
$193.96
DRISCOLL FREDERICK W
VP, CFO & Treasurer
2011-08-09 Buy
20,000
100%
$1.18
$23.60
1,000
16,337.29%
0
At Loss
14,664.94
Total 9
  • 1

DRISCOLL FREDERICK W personal network

Name Position Linked company